Characteristics and Survival of Patients with Primary and Secondary Distant Metastasis of Oropharyngeal Squamous Cell Carcinoma (OPSCC).
McGarrah Patrick W PW, Agwaze Ruth N RN, O'Byrne Jamie J, Abdel-Halim Chadi C et al.
Approximately 20% of patients with oropharyngeal squamous cell carcinoma (OPSCC) develop distant metastases (DM). Survival outcomes after DM vary widely depending on clinical and biologic factors. This study compared baseline characteristics, management strategies, and oncologic outcomes among OPSCC patients with primary and secondary DM to better inform prognostication and therapeutic planning. We conducted a retrospective cohort study of patients treated at a tertiary care center with HPV/p16-positive, HPV/p16-negative, or unknown-status OPSCC who developed DM at any point. Treatments included surgery, radiation, and systemic therapy delivered with curative or non-curative intent. Cohort characteristics and overall survival (OS), stratified by primary versus secondary DM and treatment subgroups, were assessed using chi-square tests and Kaplan Meier analyses. A total of 132 patients were included: 18 with primary DM and 114 with secondary DM. HPV-positivity was lower in primary versus secondary DM group (22.2% vs 75.4%). Median follow-up was 32.4 months. Median OS from DM diagnosis was significantly shorter for primary versus secondary DM (9.6 vs 20.4 months; HR 2.00, 95% CI 1.16-3.46). Patients with secondary DM were more likely to receive metastasis-directed therapy (MDT). Median OS was 56.4 months with MDT and 13.2 months without (HR 0.38, 95% CI 0.23-0.61). This is the largest single center analysis of DM OPSCC to date. Primary DM OPSCC was associated with worse survival and lower HPV-positivity. Patients with DM, particularly those with HPV-positive disease, may achieve extended survival following aggressive treatment such as MDT.